Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 ,inter alia, to consider and approve 'Aarti Drugs Limited - Performance ....

Ref: ADL/SE/2026-27/39 August 24, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers “Exchange Plaza”, Plot No C/1, Dalal Street, G Block, Bandra Kurla Complex, Mumbai 400 001 Bandra (E), Mumbai 400 051 NSE SYMBOL: AARTIDRUGS BSE CODE: 524348 Dear Sir/ Madam, Ref: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Intimation of Board Meeting This is to inform you that the next meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 27, 2026, to consider and approve the ‘Aarti Drugs Limited – Performance Stock Option Plan 2026’, along with matters related and incidental thereto. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for Prevention of Insider Trading, the Trading Window of the Company shall remain closed from August 25, 2026, till August 29, 2026. The above information is also available on the website of the Company: www.aartidrugs.com You are requested to take the same on records. Thanking you, Yours Faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. NO. F12932